Overexpression of NOX5 is associated with numerous human diseases, including cardiovascular diseases, nicotine-related atherosclerosis, renal injury, diabetic nephropathy, and cancers2,7, making NOX5 an attractive drug target8,9. The gene discussed is NOX5; the disease is atherosclerosis.